Our data indicate that IFN-α–mediated, IRF1-driven ATR machinery contributes to SLE pathogenesis by promoting B cell hyperactivity and demonstrate a previously unidentified pathway by which type I IFN promotes humoral immune responses. The gene discussed is IRF1; the disease is systemic lupus erythematosus.